SCHEMBL740798

SCHEMBL740798

COc1cccc(C(C)(C)NC(=O)c2cc3c(NC(=O)c4ccc(CN5CCC5)cc4)n[nH]c3s2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 2/20 0.59
BCR P11274 2/20 0.59
AURKA O14965 1/20 0.46
MAPT P10636 3/20 0.44
TP53 P04637 2/20 0.44
HSD17B10 Q99714 2/20 0.44
KDM4E B2RXH2 2/20 0.44
TSHR P16473 1/20 0.44
LMNA P02545 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
FGFR1 P11362 1/20 0.43
KDR P35968 1/20 0.42
CYP2C9 P11712 1/20 0.42
CCR2 P41597 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
KMT2A Q03164 2/20 0.40
NTRK1 P04629 1/20 0.39
FLT3 P36888 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL742323 0.98 ABL1 (0.61) ABL1BCRAURKAMAPTTP53
SCHEMBL743126 0.98 ABL1 (0.62) ABL1BCRAURKAMAPTTP53
SCHEMBL739902 0.94 LMNA (0.54) ABL1BCRAURKAMAPTTP53
SCHEMBL743418 0.93 ABL1 (0.60) ABL1BCRAURKAMAPTHSD17B10
SCHEMBL741481 0.91 ABL1 (0.62) ABL1BCRAURKAMAPTHSD17B10
SCHEMBL741724 0.90 ABL1 (0.64) ABL1BCRAURKAMAPTHSD17B10
SCHEMBL740623 0.90 ABL1 (0.72) ABL1BCRAURKAMAPTKDM4E
SCHEMBL741731 0.90 ABL1 (0.61) ABL1BCRAURKAMAPTTP53
SCHEMBL742638 0.89 ABL1 (0.74) ABL1BCRAURKAMAPTKDM4E
SCHEMBL740581 0.88 ABL1 (0.63) ABL1BCRAURKAMAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed